Halper Sadeh Probes Potential Shareholder Rights Violations at Three Firms

The New York-based firm is examining Weave Communications' $7.40 per share cash sale to Francisco Partners, questioning whether the terms stifle superior offers. Simultaneously, the investigation into Fulcrum Therapeutics focuses on its merger with Slate Medicines, which leaves existing shareholders with a 5.0% stake in the combined entity. Blue Ridge Bankshares is also under review following its agreement to merge with HomeTrust Bancshares, a deal set to exchange Blue Ridge stock for 0.086 shares of HomeTrust common stock.

Halper Sadeh LLC contends that these transactions may involve breaches of fiduciary duties or violations of federal securities laws. Attorneys Daniel Sadeh and Zachary Halper are currently evaluating whether to pursue increased consideration or enhanced disclosures for affected investors. The firm operates on a contingent fee basis for these matters, asserting that its past interventions have secured corporate reforms and financial recoveries for global investors involved in securities fraud litigation.